Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilseob Choi

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|December 23, 2022
Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast CancerSoyoung Kim, Ilseob Choi, Ik-Hwan Han, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 3, 2024
Therapeutic effects of MEL-dKLA by targeting M2 macrophages in pulmonary fibrosisIlseob Choi, Ik-Hwan Han, Nari Cha, et al.
Frontiers in Immunology|June 19, 2026
STAT6 inhibition of M2 macrophages suppresses tumor growth by modulating the tumor microenvironment in colon cancer modelGeumseong Yeun, Ik-Hwan Han, Ilseob Choi, et al.
Frontiers in Immunology|September 29, 2025
Immunomodulatory peptide-drug conjugate MEL-dKLA suppresses progression of prostate cancer by eliminating M2-like tumor-associated macrophagesIk-Hwan Han, Ilseob Choi, Soyoung Kim, et al.
Frontiers in Pharmacology|January 23, 2023
The involvement of the noradrenergic system in the antinociceptive effect of cucurbitacin D on mice with paclitaxel-induced neuropathic painKeun-Tae Park, Suyong Kim, Ilseob Choi, et al.
International Journal of Molecular Sciences|April 3, 2021
Magnoliae Cortex Alleviates Muscle Wasting by Modulating M2 Macrophages in a Cisplatin-Induced Sarcopenia Mouse ModelMinwoo Hong, Ik-Hwan Han, Ilseob Choi, et al.
NPJ Precision Oncology|April 9, 2026
CD18-targeted peptide-drug conjugate remodels the immunosuppressive tumor microenvironment of prostate cancer by selective depletion of M2 macrophagesIk-Hwan Han, Ilseob Choi, Soyoung Kim, et al.
Nature Communications|October 19, 2021
Context value updating and multidimensional neuronal encoding in the retrosplenial cortexWeilun Sun, Ilseob Choi, Stoyan Stoyanov, et al.
Frontiers in Immunology|May 1, 2023
Melittin derived peptide-drug conjugate, M-DM1, inhibits tumor progression and induces effector cell infiltration in melanoma by targeting M2 tumor-associated macrophagesChanmi Jeong, Jeongdong Kim, Ik-Hwan Han, et al.
Glia|September 1, 2020
Attenuation of the extracellular matrix restores microglial activity during the early stage of amyloidosisStoyan Stoyanov, Weilun Sun, Henning Peter Düsedau, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|December 23, 2022
Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast CancerSoyoung Kim, Ilseob Choi, Ik-Hwan Han, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 3, 2024
Therapeutic effects of MEL-dKLA by targeting M2 macrophages in pulmonary fibrosisIlseob Choi, Ik-Hwan Han, Nari Cha, et al.
Frontiers in Immunology|June 19, 2026
STAT6 inhibition of M2 macrophages suppresses tumor growth by modulating the tumor microenvironment in colon cancer modelGeumseong Yeun, Ik-Hwan Han, Ilseob Choi, et al.
Frontiers in Immunology|September 29, 2025
Immunomodulatory peptide-drug conjugate MEL-dKLA suppresses progression of prostate cancer by eliminating M2-like tumor-associated macrophagesIk-Hwan Han, Ilseob Choi, Soyoung Kim, et al.
Frontiers in Pharmacology|January 23, 2023
The involvement of the noradrenergic system in the antinociceptive effect of cucurbitacin D on mice with paclitaxel-induced neuropathic painKeun-Tae Park, Suyong Kim, Ilseob Choi, et al.
International Journal of Molecular Sciences|April 3, 2021
Magnoliae Cortex Alleviates Muscle Wasting by Modulating M2 Macrophages in a Cisplatin-Induced Sarcopenia Mouse ModelMinwoo Hong, Ik-Hwan Han, Ilseob Choi, et al.
NPJ Precision Oncology|April 9, 2026
CD18-targeted peptide-drug conjugate remodels the immunosuppressive tumor microenvironment of prostate cancer by selective depletion of M2 macrophagesIk-Hwan Han, Ilseob Choi, Soyoung Kim, et al.
Nature Communications|October 19, 2021
Context value updating and multidimensional neuronal encoding in the retrosplenial cortexWeilun Sun, Ilseob Choi, Stoyan Stoyanov, et al.
Frontiers in Immunology|May 1, 2023
Melittin derived peptide-drug conjugate, M-DM1, inhibits tumor progression and induces effector cell infiltration in melanoma by targeting M2 tumor-associated macrophagesChanmi Jeong, Jeongdong Kim, Ik-Hwan Han, et al.
Glia|September 1, 2020
Attenuation of the extracellular matrix restores microglial activity during the early stage of amyloidosisStoyan Stoyanov, Weilun Sun, Henning Peter Düsedau, et al.
Pageof 2